Blachut, B., Thaker, P., Powell, M., Smitherman, C., Secord, A. A., Washington, C., … Mullen, M. (2024). PT010/#827  DNA damage response alterations within molecular subgroups of endometrial cancer and association with platinum chemotherapy response: an endometrial cancer molecularly targeted therapy consortium study. In Short Oral Abstracts (Regular Submission) (p. A32.2-A33). BMJ Publishing Group Ltd. https://doi.org/10.1136/ijgc-2024-igcs.33

Blachut, Barbara, Premal Thaker, Matthew Powell, Carson Smitherman, Angeles Alvarez Secord, Christina Washington, Kathleen Moore, et al. “PT010/#827  DNA damage response alterations within molecular subgroups of endometrial cancer and association with platinum chemotherapy response: an endometrial cancer molecularly targeted therapy consortium study.” In Short Oral Abstracts (Regular Submission), A32.2-A33. BMJ Publishing Group Ltd, 2024. https://doi.org/10.1136/ijgc-2024-igcs.33.

Blachut B, Thaker P, Powell M, Smitherman C, Secord AA, Washington C, et al. PT010/#827  DNA damage response alterations within molecular subgroups of endometrial cancer and association with platinum chemotherapy response: an endometrial cancer molecularly targeted therapy consortium study. In: Short Oral Abstracts (Regular Submission). BMJ Publishing Group Ltd; 2024. p. A32.2-A33.

Blachut, Barbara, et al. “PT010/#827  DNA damage response alterations within molecular subgroups of endometrial cancer and association with platinum chemotherapy response: an endometrial cancer molecularly targeted therapy consortium study.” Short Oral Abstracts (Regular Submission), BMJ Publishing Group Ltd, 2024, p. A32.2-A33. Crossref, doi:10.1136/ijgc-2024-igcs.33.

Blachut B, Thaker P, Powell M, Smitherman C, Secord AA, Washington C, Moore K, Haight P, Cosgrove C, Crafton S, Pothuri B, Klein M, Bae-Jump V, Chase D, Gaillard S, Wright J, Jackson A, Ko E, Corr B, Puechl A, Konecny G, Duska L, Castellano T, Ketch P, Toboni M, Hacker K, Zhao P, Mullen M. PT010/#827  DNA damage response alterations within molecular subgroups of endometrial cancer and association with platinum chemotherapy response: an endometrial cancer molecularly targeted therapy consortium study. Short Oral Abstracts (Regular Submission). BMJ Publishing Group Ltd; 2024. p. A32.2-A33.